文献速递妇科产科

子宫内膜异位症与癌症风险的系统综述与荟萃分析

Endometriosis and cancer: a systematic review and meta-analysis.
PubMed 文献 · Hum Reprod Update · 2021-01-01

结果显示子宫内膜异位症与卵巢癌(SRR=1.93,95%CI=1.68-2.22)和甲状腺癌(SRR=1.39,95%CI=1.24-1.57)风险升高相关,与宫颈癌风险降低相关(SRR=0.68,95%CI=0.56-0.82),但与乳腺癌关联微弱(SRR=1.04,95%CI=1.00-1.09),与结直肠癌无关联。多数研究存在严重偏倚风险,异质性显著,卵巢癌分析存在发表偏倚。

要点

  • 子宫内膜异位症与卵巢癌风险升高相关,尤其透明细胞癌和子宫内膜样癌组织学亚型。
  • 子宫内膜异位症与甲状腺癌风险升高相关,与乳腺癌关联微弱,与结直肠癌无关联。
  • 与宫颈癌的负相关可能反映诊断机会增加而非因果保护,需谨慎解读。

核心结论

  • 子宫内膜异位症与卵巢癌和甲状腺癌风险升高相关,与乳腺癌关联微弱,与宫颈癌风险降低相关。
  • 多数纳入研究存在严重或极严重偏倚风险,研究间异质性显著,卵巢癌分析存在发表偏倚。
  • 因果推断需要时间顺序证据,但许多研究未考虑此因素。

研究设计与样本

  • 采用随机效应模型估计汇总相对风险(SRR)和95%置信区间(CI),使用Q检验和I2统计量评估异质性,Egger和Begg检验评估发表偏倚,ROBINS-I工具评估偏倚风险。

主要发现

  • 卵巢癌风险升高(SRR=1.93,95%CI=1.68-2.22;n=24项研究),透明细胞癌(SRR=3.44,95%CI=2.82-4.42;n=5项研究)和子宫内膜样癌(SRR=2.33,95%CI=1.82-2.98;n=5项研究)关联更强,异质性P<0.0001,发表偏倚检验P<0.01。
  • 甲状腺癌风险升高(SRR=1.39,95%CI=1.24-1.57;n=5项研究)。
  • 乳腺癌关联微弱(SRR=1.04,95%CI=1.00-1.09;n=20项研究),结直肠癌无关联(SRR=1.00,95%CI=0.87-1.16;n=5项研究)。
  • 子宫内膜癌总体无统计学显著关联(SRR=1.23,95%CI=0.97-1.57;n=17项研究),限制于前瞻性队列研究时关联完全无效(SRR=0.99,95%CI=0.72-1.37;n=5项研究)。
  • 皮肤黑色素瘤总体无显著关联(SRR=1.17,95%CI=0.97-1.41;n=7项研究),但限制于低/中度偏倚风险研究时关联增大且有统计学意义(SRR=1.71,95%CI=1.24-2.36;n=2项研究);宫颈癌风险降低(SRR=0.68,95%CI=0.56-0.82;n=4项研究),但可能反映检测机会增加而非因果。

临床怎么用

  • 临床医生应知晓子宫内膜异位症患者卵巢癌和甲状腺癌风险可能升高,但需结合偏倚风险和研究异质性谨慎解读。
  • 对于子宫内膜异位症患者,尤其卵巢透明细胞癌和子宫内膜样癌风险升高,应关注卵巢癌的筛查与早期识别。
  • 宫颈癌风险降低可能源于更频繁的妇科检查,不应因此降低宫颈癌筛查力度。

局限性

  • 研究间异质性显著,卵巢癌分析存在发表偏倚。
  • 许多研究未考虑时间顺序,限制因果推断。
  • 部分癌症类型分析基于少于4项研究,结果不稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Endometriosis is an often chronic, inflammatory gynaecologic condition affecting 190 million women worldwide. Studies have reported an elevated cancer risk among patients with endometriosis. However, prior research has included methodologic issues that impede valid and robust interpretation. OBJECTIVE AND RATIONALE: We conducted a meta-analysis of studies investigating the association between endometriosis and cancer risk and analysed the results by methodologic characteristics. We discuss the implications of cancer screening in patients and management challenges faced by clinicians. SEARCH METHODS: We searched PubMed and Embase databases for eligible studies from inception through 24 October 2019. We included cohort and case-control studies examining the association between endometriosis and cancer risk; cross-sectional studies and case reports were excluded. Publications had to present risk/rate/odds estimates with 95% CI. Random effects meta-analysis was used to estimate summary relative risks (SRR) and CIs. Heterogeneity across studies was assessed by the Q test and I2 statistics, and publication bias using Egger's and Begg's tests. Risk of bias and quality of the included studies were assessed using the risk of bias in non-randomized studies of interventions (ROBINS-I) tool. OUTCOMES: Forty-nine population-based case-control and cohort studies were included. Twenty-six studies were scored as having a 'serious'/'critical' risk of bias, and the remaining 23 'low'/'moderate'. Cancer-specific analyses showed a positive association between endometriosis and ovarian cancer risk (SRR = 1.93, 95% CI = 1.68-2.22; n = 24 studies) that was strongest for clear cell (SRR = 3.44, 95% CI = 2.82-4.42; n = 5 studies) and endometrioid (SRR = 2.33, 95% CI = 1.82-2.98; n = 5 studies) histotypes (Pheterogeneity < 0.0001), although with significant evidence of both heterogeneity across studies and publication bias (Egger's and Begg's P-values < 0.01). A robust association was observed between endometriosis and thyroid cancer (SRR = 1.39, 95% CI =1.24-1.57; n = 5 studies), a very small association with breast cancer (SRR = 1.04, 95% CI =1.00-1.09; n = 20 studies) and no association with colorectal cancer (SRR = 1.00, 95% CI =0.87-1.16; n = 5 studies). The association with endometrial cancer was not statistically significant (SRR = 1.23, 95% CI =0.97-1.57; n = 17 studies) overall and wholly null when restricted to prospective cohort studies (SRR = 0.99, 95% CI =0.72-1.37; n = 5 studies). The association with cutaneous melanoma was also non-significant (SRR = 1.17, 95% CI =0.97-1.41; n = 7 studies) but increased in magnitude and was statistically significant when restricted to studies with low/moderate risk of bias (SRR = 1.71, 95% CI = 1.24-2.36, n = 2 studies). The most robust finding both in terms of statistical significance and magnitude of effect was an inverse association with cervical cancer (SRR = 0.68, 95% CI =0.56-0.82; n = 4 studies); however, this result has a high potential to reflect heightened access to detection of dysplasia for women who reached an endometriosis diagnosis and is thus likely not causal. Several additional cancer types were explored based on <4 studies. WIDER IMPLICATIONS: Endometriosis was associated with a higher risk of ovarian and thyroid, and minimally (only 4% greater risk) with breast cancer, and with a lower risk of cervical cancer. However, this meta-analysis confirms that: a majority of studies had severe/critical risk of bias; there is impactful heterogeneity across studies-and for ovarian cancer, publication bias; and causal inference requires temporality, which in many studies was not considered. We discuss the implications of these potential associations from the perspectives of patients with endometriosis, clinicians involved in their care, and scientists investigating their long-term health risks.

来源:Hum Reprod Update,查看原文。版权归原作者所有。

引用

  1. Kvaskoff M, Mahamat-Saleh Y, Farland LV, et al. Endometriosis and cancer: a systematic review and meta-analysis. Hum Reprod Update. 2021. PMID: 33202017. doi:10.1093/humupd/dmaa045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。